Cargando…
Oligopeptide-modified poly(beta-amino ester)s-coated AdNuPARmE1A: Boosting the efficacy of intravenously administered therapeutic adenoviruses
Oncolytic adenoviruses are used as agents for the treatment of cancer. However, their potential is limited due to the high seroprevalence of anti-adenovirus neutralizing antibodies (nAbs) within the population and the rapid liver sequestration when systemically administered. To overcome these challe...
Autores principales: | Brugada-Vilà, Pau, Cascante, Anna, Lázaro, Miguel Ángel, Castells-Sala, Cristina, Fornaguera, Cristina, Rovira-Rigau, Maria, Albertazzi, Lorenzo, Borros, Salvador, Fillat, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052890/ https://www.ncbi.nlm.nih.gov/pubmed/32194832 http://dx.doi.org/10.7150/thno.40902 |
Ejemplares similares
-
Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas
por: Fornaguera, Cristina, et al.
Publicado: (2018) -
Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy
por: Arista-Romero, Maria, et al.
Publicado: (2021) -
Complex pBAE Nanoparticle Cell Trafficking: Tracking Both Position and Composition Using Super Resolution Microscopy
por: Riera, Roger, et al.
Publicado: (2022) -
Eleazar Parmly
Publicado: (1875) -
Implications of MicroRNAs in Oncolytic Virotherapy
por: Bofill-De Ros, Xavier, et al.
Publicado: (2017)